Literature DB >> 26756638

Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

John D Imig1, Md Abdul Hye Khan1.   

Abstract

Arachidonic acid metabolites have a myriad of biological actions including effects on the kidney to alter renal hemodynamics and tubular transport processes. Cyclooxygenase metabolites are products of an arachidonic acid enzymatic pathway that has been extensively studied in regards to renal function. Two lesser-known enzymatic pathways of arachidonic acid metabolism are the lipoxygenase (LO) and cytochrome P450 (CYP) pathways. The importance of LO and CYP metabolites to renal hemodynamics and tubular transport processes is now being recognized. LO and CYP metabolites have actions to alter renal blood flow and glomerular filtration rate. Proximal and distal tubular sodium transport and fluid and electrolyte homeostasis are also significantly influenced by renal CYP and LO levels. Metabolites of the LO and CYP pathways also have renal actions that influence renal inflammation, proliferation, and apoptotic processes at vascular and epithelial cells. These renal LO and CYP pathway actions occur through generation of specific metabolites and cell-signaling mechanisms. Even though the renal physiological importance and actions for LO and CYP metabolites are readily apparent, major gaps remain in our understanding of these lipid mediators to renal function. Future studies will be needed to fill these major gaps regarding LO and CYP metabolites on renal function.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26756638      PMCID: PMC5965260          DOI: 10.1002/cphy.c150009

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  150 in total

1.  Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.

Authors:  J D Imig; B T Pham; E A LeBlanc; K M Reddy; J R Falck; E W Inscho
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

Review 2.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

3.  Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.

Authors:  Ming-Zhi Zhang; Yinqiu Wang; Bing Yao; Leslie Gewin; Shouzuo Wei; Jorge H Capdevila; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

4.  Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.

Authors:  Kiyoshi Nakagawa; Vijaykumar R Holla; Yuan Wei; Wen-Hui Wang; Arnaldo Gatica; Shouzou Wei; Shaojun Mei; Crystal M Miller; Dae Ryong Cha; Edward Price; Roy Zent; Ambra Pozzi; Matthew D Breyer; Youfei Guan; John R Falck; Michael R Waterman; Jorge H Capdevila
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

Review 5.  Epoxyeicosatrienoic acid analogs and vascular function.

Authors:  V Sudhahar; S Shaw; J D Imig
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  Glomerular cytochrome P-450 and cyclooxygenase metabolites regulate efferent arteriole resistance.

Authors:  Hong Wang; Jeffrey L Garvin; John R Falck; YiLin Ren; Steadman S Sankey; Oscar A Carretero
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

8.  Five-lipoxygenase products in glomerular immune injury.

Authors:  K F Badr
Journal:  J Am Soc Nephrol       Date:  1992-10       Impact factor: 10.121

Review 9.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.

Authors:  Cheng-Chia Wu; Shaojun Mei; Jennifer Cheng; Yan Ding; Adam Weidenhammer; Victor Garcia; Fan Zhang; Katherine Gotlinger; Vijaya L Manthati; John R Falck; Jorge H Capdevila; Michal L Schwartzman
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

View more
  8 in total

Review 1.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

2.  Lipoxygenases modulate the effect of glutoxim on Na+ transport in the frog skin epithelium.

Authors:  Z I Krutetskaya; A V Melnitskaya; V G Antonov; A D Nozdrachev
Journal:  Dokl Biochem Biophys       Date:  2017-07-20       Impact factor: 0.788

Review 3.  Diurnal Regulation of Renal Electrolyte Excretion: The Role of Paracrine Factors.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Annu Rev Physiol       Date:  2019-10-21       Impact factor: 19.318

Review 4.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

Review 5.  Regulation of Tissue Inflammation by 12-Lipoxygenases.

Authors:  Abhishek Kulkarni; Jerry L Nadler; Raghavendra G Mirmira; Isabel Casimiro
Journal:  Biomolecules       Date:  2021-05-11

Review 6.  Renal metabolism and hypertension.

Authors:  Zhongmin Tian; Mingyu Liang
Journal:  Nat Commun       Date:  2021-02-11       Impact factor: 14.919

7.  Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney.

Authors:  Makoto Arita; Eisei Sohara; Naohiro Takahashi; Hiroaki Kikuchi; Ayaka Usui; Taisuke Furusho; Takuya Fujimaru; Tamami Fujiki; Tomoki Yanagi; Yoshiaki Matsuura; Kenichi Asano; Kouhei Yamamoto; Fumiaki Ando; Koichiro Susa; Shintaro Mandai; Takayasu Mori; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2021-02-17       Impact factor: 2.801

Review 8.  Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review.

Authors:  Nada Božina; Lana Ganoci; Livija Simičević; Katarina Gvozdanović; Iva Klarica Domjanović; Margareta Fistrek Prlić; Tena Križ; Ana Borić Bilušić; Mario Laganović; Tamara Božina
Journal:  Arh Hig Rada Toksikol       Date:  2021-06-28       Impact factor: 2.078

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.